Announced details
The first unit has already been delivered to Osaka Metropolitan University. No information is provided on cumulative usage or the number of companies adopting the product.
Rigaku Corporation, a group company of Rigaku, is collaborating with Osaka Metropolitan University. Rigaku is participating in the user roundtable as a technology sponsor, and the university has already received the first MoleQlyze unit.
The headquarters appears to be located in Osaka Prefecture, but the disclosure does not provide details of the location, representative, capital or year of establishment. The university will establish its Graduate School of Drug Discovery Science in April 2026 and is strengthening its drug discovery research. It has been selected for the Ministry of Education, Culture, Sports, Science and Technology's J-PEAKS program, the Program for Promoting the Development of Research Universities as Regional Core and Distinctive Research Universities.
No information is provided on the impact on business performance.
The company does not address Contract Value / Offering price.
Ministry of Education, Culture, Sports, Science and Technology, "Program for Promoting the Development of Research Universities as Regional Core and Distinctive Research Universities (J-PEAKS)"
| Item | Details |
|---|---|
| Names of Products / Services Covered | Electron density topography (EDT) instrument BioMAXS/EDT (current product name: MoleQlyze) |
| Counterparty | Osaka Metropolitan University |
| Counterparty overview | The headquarters appears to be located in Osaka Prefecture, but the disclosure does not provide details of the location, representative, capital or year of establishment. The university will establish its Graduate School of Drug Discovery Science in April 2026 and is strengthening its drug discovery research. It has been selected for the Ministry of Education, Culture, Sports, Science and Technology's J-PEAKS program, the Program for Promoting the Development of Research Universities as Regional Core and Distinctive Research Universities. |
| Relationship with the Company | Rigaku Corporation, a group company of Rigaku, is collaborating with Osaka Metropolitan University. Rigaku is participating in the user roundtable as a technology sponsor, and the university has already received the first MoleQlyze unit. |
| Launch date | April 2026 (user roundtable; planned start of the initiative) |
| Applicable area | Drug Discovery Research, Research and development of biopharmaceuticals such as antibody drugs, Research and development of drug delivery systems, Life sciences research |
| Usage history | The first unit has already been delivered to Osaka Metropolitan University. No information is provided on cumulative usage or the number of companies adopting the product. |
| Impact on Business Performance | No information is provided on the impact on business performance. |
| Source | Ministry of Education, Culture, Sports, Science and Technology, "Program for Promoting the Development of Research Universities as Regional Core and Distinctive Research Universities (J-PEAKS)" |
Items this document does not state (9)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Osaka Metropolitan University is strengthening its drug discovery research, and MoleQlyze is highly compatible with research on biopharmaceuticals such as antibody drugs. In addition, against the backdrop of the university's selection for J-PEAKS, the initiative is expected to generate new research results and expand the scope of applications.